Health
The Man Who Spiked Up The Price of Daraprim, Martin Shkreli, Found Guilty of Three Counts of Securities Fraud
On Friday, August 4th, the infamous “Pharma bro” Martin Shkreli was found guilty of three counts of securities fraud. However, he was found not guilty of five other crimes he had been accused of regarding ... [Read]
Biotechnology
This is Why Ocular Therapeutix Inc.’s Stock Today Fell Despite its Rising Yesterday — July 12, 2017
Ocular Therapeutix’s (NASDAQ:$OCUL) stock fell again on July 12 by 20.5% as of 12:55 PM EDT. The stock fell after news broke out that Ocular received a complete response letter (CRL) for its lead drug ... [Read]
Biotechnology
Arena Pharmaceuticals Shares Gained 45% Today
If you’re looking for pharmaceutical companies to invest in, you might want to brush up on what’s been happening in the sector as of late. After Arena Pharmaceuticals (NASDAQ:$ARNA) announced that its experimental pulmonary arterial ... [Read]
Health
An Analyst Upgraded TherapeuticsMD Stock from “Perform” to “Outperform” Today
On Tuesday, after Jay Olson, an analyst at Oppenheimer, upgraded TherapeuticsMD (NYSEMKT:$TXMD) stock from “Perform” to “Outperform”, shares of TXMD increased 18%. Additionally, the analyst gave TherapeuticsMD shares a $10 price target, which means that ... [Read]
Biotechnology
This Is Why Ocular Therapeutix Inc.’s Stock Hit the Ceiling Today – July 11, 2017
A few days ago, shares of biopharmaceutical startup Ocular Therapeutix (NASDAQ:$OCUL) were plummeting — but on July 11, the company’s shares shot up by 26%. This is largely due to the fact that Ocular Therapeutix ... [Read]
Biotechnology
This is Why Shares of Ocular Therapeutix Inc. Spiraled Today – July 7, 2017
As of around 4:50 PM EDT on July 7, 2017, Ocular Therapeutix Inc.’s (NASDAQ:$OCUL) stocks have fallen by 25.05% to $7.12 from its $9.05 opening this morning. The dramatic fall occurred after Adam Feuerstein at ... [Read]
Drug Manufacturers
Adamis Pharmaceuticals’ Shares Hits New Highs After Allergic-Reaction Treatment Drug Gains FDA Approval
Investors in Adamis Pharmaceuticals Corp. (NASDAQ:$ADMP) were probably celebrating yesterday as the company’s shares flew through the roof by a whopping 53%, hitting a one-year high. The rise was largely due to Adamis’ announcement that ... [Read]
Biotechnology
Epizyme Stock Rises with Positive Media Coverage, According to Analysis
Media coverage of biopharmaceutical company Epizyme (NASDAQ:$EPZM) has been pretty positive recently, according to research group Alpha One Sentiment Analysis. Alpha One helps company identify positive and/or negative media coverage through the analysis of more ... [Read]
Drug Manufacturers
Oasmia Pharmaceutical’s Stock Increases After Company Signs Deal with Hetero Group
If you’re looking for the best pharmaceutical companies to invest in, you should know that Oasmia Pharmaceutical AB (STO:$OASM), a Swedish company that focuses on the development of drugs within the fields of human and ... [Read]
Biotechnology
RedHill Biopharma Ltd – ADR Stock Rises After Positive Phase III Results of BEKINDA Treatment
Israel-based biopharmaceutical company RedHill Biopharma Ltd – ADR (NASDAQ:$RDHL) saw its stocks rise after the company’s release of the results from its Phase III clinical trial named GUARD. GUARD tested the performance of using RHB-102 ... [Read]